drugset
Drugs / Fluzone
last change Jul 2021 re-read 3 minutes ago

Fluzone

also known as QIV

Vaccine

Developed for
influenza
Investigated by
CHU de Quebec-Universite Laval · Canadian Center for Vaccinology · Canadian Immunization Research Network · Dalhousie University · McGill University Health Centre/Research Institute of the McGill University Health Centre · Provincial Health Services Authority British Columbia
+1 more · University of Montreal

Trials 1

today NCT03669627 · Ph 2
20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03669627 Nov 2018 → Jul 2021 influenza Canadian Immunization Research Network Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Fluzone “Two doses (0.5 mL) QIV (Fluzone) received one month apart in year 1. One dose (0.5 mL) QIV (Fluzone) received as booster in year 2.” NCT03669627 ↗
Known as QIV ClinicalTrials.gov intervention name — accepted as the source's own label NCT03669627 ↗
Modality Vaccine “unadjuvanted quadrivalent influenza vaccine” NCT03669627 ↗